MOSCOW (Reuters) – Russia’s Supreme Court on Thursday rejected a lawsuit from U.S. company Gilead Sciences challenging the Russian government’s decision last year to let a Russian pharmaceutical firm develop the COVID-19 drug remdesivir without Gilead’s consent.
Pharmasyntez on Tuesday shipped a generic version of the drug – called Remdeform – to India as part of humanitarian aid contributions.
(Reporting by Polina Nikolskaya; Writing by Alexander Marrow; Editing by Alex Richardson)
